BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34921727)

  • 21. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
    Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.
    Park IU; Wojtal N; Silverberg MJ; Bauer HM; Hurley LB; Manos MM
    PLoS One; 2015; 10(3):e0118938. PubMed ID: 25793987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The added value of digital imaging to reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: A prospective cohort study.
    Wiersma D; Vinke A; Siebers AG; Melchers WJG; Bekkers RLM; Loopik DL
    BJOG; 2023 Jan; 130(2):184-191. PubMed ID: 35993438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
    Gök M; van Kemenade FJ; Heideman DA; Berkhof J; Rozendaal L; Spruyt JW; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
    Int J Cancer; 2012 Mar; 130(5):1128-35. PubMed ID: 21484793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions.
    Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM
    Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.
    Berkhof J; de Bruijne MC; Zielinski GD; Bulkmans NW; Rozendaal L; Snijders PJ; Verheijen RH; Meijer CJ
    Int J Cancer; 2006 Apr; 118(7):1759-68. PubMed ID: 16217759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.
    Verdoodt F; Szarewski A; Halfon P; Cuschieri K; Arbyn M
    Cancer Cytopathol; 2013 Dec; 121(12):675-87. PubMed ID: 23881840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening.
    Harper DM; Anderson RJ; Baker E; Yu TM
    Cancer Prev Res (Phila); 2023 Jul; 16(7):393-404. PubMed ID: 37210751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.
    Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Hesselink AT; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij WM; Snijders PJ; Meijer CJ
    Int J Cancer; 2012 Feb; 130(3):602-10. PubMed ID: 21400507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
    Volesky KD; Magnan S; Mayrand MH; Isidean SD; El-Zein M; Comète E; Franco EL; Coutlée F
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):851-857. PubMed ID: 35131879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland.
    Jakobsson M; Tarkkanen J; Auvinen E; Häkkinen R; Laurila P; Tapper AM
    Int J STD AIDS; 2012 Jul; 23(7):485-9. PubMed ID: 22844002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of high-risk human papillomavirus DNA detection between urine and cervical sample testing in women with abnormal Pap smears.
    Punyashthira A; Horthongkham N; Jaishuen A; Jareemit N; Achariyapota V
    J Obstet Gynaecol Res; 2022 Feb; 48(2):448-455. PubMed ID: 34750932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
    Stanczuk G; Baxter G; Currie H; Lawrence J; Cuschieri K; Wilson A; Arbyn M
    BMJ Open; 2016 Apr; 6(4):e010660. PubMed ID: 27113237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation for cervical cancer screening: a training set in China.
    Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
    Clin Epigenetics; 2020 Jun; 12(1):91. PubMed ID: 32576279
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.